nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—EDNRA—intracranial aneurysm	0.985	1	CbGaD
Irbesartan—AGTR1—ACE Inhibitor Pathway—NOS3—intracranial aneurysm	0.00054	0.0376	CbGpPWpGaD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.000462	0.0321	CbGpPWpGaD
Irbesartan—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.000407	0.0283	CbGpPWpGaD
Irbesartan—EDNRA—Endothelin Pathways—NOS3—intracranial aneurysm	0.000405	0.0282	CbGpPWpGaD
Irbesartan—JUN—IL6-mediated signaling events—TIMP1—intracranial aneurysm	0.000397	0.0276	CbGpPWpGaD
Irbesartan—JUN—RAC1 signaling pathway—NCF1—intracranial aneurysm	0.000386	0.0268	CbGpPWpGaD
Irbesartan—AGTR1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.000379	0.0264	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.000329	0.0229	CbGpPWpGaD
Irbesartan—JUN—Endothelins—EDNRA—intracranial aneurysm	0.000322	0.0224	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.000289	0.0201	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—MMP2—intracranial aneurysm	0.000267	0.0185	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—intracranial aneurysm	0.000243	0.0169	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—intracranial aneurysm	0.000243	0.0169	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.000236	0.0164	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—intracranial aneurysm	0.000231	0.0161	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—intracranial aneurysm	0.000228	0.0158	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—CCL2—intracranial aneurysm	0.00022	0.0153	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.000218	0.0151	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—intracranial aneurysm	0.000217	0.0151	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—AGER—intracranial aneurysm	0.000213	0.0148	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—MMP9—intracranial aneurysm	0.0002	0.0139	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—AGER—intracranial aneurysm	0.000193	0.0134	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.000181	0.0126	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.00018	0.0125	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.000178	0.0124	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—CCL2—intracranial aneurysm	0.000177	0.0123	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—NCF1—intracranial aneurysm	0.000176	0.0122	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.000174	0.0121	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—intracranial aneurysm	0.000174	0.0121	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.000173	0.012	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.00017	0.0118	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.000164	0.0114	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000162	0.0112	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000162	0.0112	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—STARD13—intracranial aneurysm	0.000161	0.0112	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.000161	0.0112	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.000159	0.0111	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.000157	0.0109	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—CST3—intracranial aneurysm	0.000155	0.0108	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—AGER—intracranial aneurysm	0.000154	0.0107	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—MMP2—intracranial aneurysm	0.000149	0.0104	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.000146	0.0101	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.000146	0.0101	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—AGER—intracranial aneurysm	0.00014	0.00974	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00014	0.00971	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—AGER—intracranial aneurysm	0.000139	0.00964	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.000136	0.00948	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.000131	0.00907	CbGpPWpGaD
Irbesartan—JUN—FGF signaling pathway—MMP9—intracranial aneurysm	0.000128	0.00893	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STARD13—intracranial aneurysm	0.000127	0.0088	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—intracranial aneurysm	0.000125	0.00868	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00012	0.00832	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.000117	0.00815	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.000116	0.00808	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—MMP9—intracranial aneurysm	0.000112	0.00779	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.000112	0.00779	CbGpPWpGaD
Irbesartan—JUN—artery—intracranial aneurysm	0.000111	0.201	CbGeAlD
Irbesartan—JUN—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.000109	0.00761	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.000104	0.00726	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC25A16—intracranial aneurysm	9.72e-05	0.00676	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STARD13—intracranial aneurysm	9.46e-05	0.00658	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—intracranial aneurysm	9.38e-05	0.00652	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—EDNRA—intracranial aneurysm	9.11e-05	0.00633	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	8.79e-05	0.00611	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	8.49e-05	0.0059	CbGpPWpGaD
Irbesartan—AGTR1—artery—intracranial aneurysm	8.36e-05	0.152	CbGeAlD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	8.14e-05	0.00566	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—MMP2—intracranial aneurysm	7.98e-05	0.00554	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CTSS—intracranial aneurysm	7.66e-05	0.00532	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	7.51e-05	0.00522	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CTSK—intracranial aneurysm	7.05e-05	0.0049	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	6.89e-05	0.00479	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	6.65e-05	0.00462	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ASAH1—intracranial aneurysm	6.44e-05	0.00447	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	5.9e-05	0.0041	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CTSB—intracranial aneurysm	5.83e-05	0.00405	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCL2—intracranial aneurysm	5.72e-05	0.00398	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	5.48e-05	0.00381	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	5.26e-05	0.00366	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—EDNRA—intracranial aneurysm	5.15e-05	0.00358	CbGpPWpGaD
Irbesartan—JUN—brainstem—intracranial aneurysm	4.73e-05	0.0858	CbGeAlD
Irbesartan—AGTR1—Signaling by GPCR—EDNRA—intracranial aneurysm	4.68e-05	0.00325	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL2—intracranial aneurysm	4.49e-05	0.00312	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTSS—intracranial aneurysm	4.46e-05	0.0031	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	4.28e-05	0.00298	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTSK—intracranial aneurysm	4.1e-05	0.00285	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—AGER—intracranial aneurysm	3.77e-05	0.00262	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NCF1—intracranial aneurysm	3.73e-05	0.00259	CbGpPWpGaD
Irbesartan—PTGS1—artery—intracranial aneurysm	3.68e-05	0.0667	CbGeAlD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	3.66e-05	0.00254	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ASAH1—intracranial aneurysm	3.63e-05	0.00252	CbGpPWpGaD
Irbesartan—EDNRA—medulla oblongata—intracranial aneurysm	3.61e-05	0.0655	CbGeAlD
Irbesartan—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	3.54e-05	0.00246	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTSB—intracranial aneurysm	3.4e-05	0.00236	CbGpPWpGaD
Irbesartan—JUN—Immune System—NCF1—intracranial aneurysm	3.38e-05	0.00235	CbGpPWpGaD
Irbesartan—EDNRA—midbrain—intracranial aneurysm	3.3e-05	0.0599	CbGeAlD
Irbesartan—JUN—medulla oblongata—intracranial aneurysm	3.3e-05	0.0598	CbGeAlD
Irbesartan—JUN—midbrain—intracranial aneurysm	3.01e-05	0.0547	CbGeAlD
Irbesartan—EDNRA—Signaling by GPCR—CCL2—intracranial aneurysm	2.94e-05	0.00204	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NCF1—intracranial aneurysm	2.93e-05	0.00203	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	2.9e-05	0.00202	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	2.88e-05	0.002	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EDNRA—intracranial aneurysm	2.76e-05	0.00192	CbGpPWpGaD
Irbesartan—AGTR1—medulla oblongata—intracranial aneurysm	2.48e-05	0.045	CbGeAlD
Irbesartan—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	2.46e-05	0.00171	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	2.34e-05	0.00163	CbGpPWpGaD
Irbesartan—JUN—cerebellum—intracranial aneurysm	2.33e-05	0.0423	CbGeAlD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—intracranial aneurysm	2.3e-05	0.0016	CbGpPWpGaD
Irbesartan—JUN—Immune System—AGER—intracranial aneurysm	2.19e-05	0.00152	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NCF1—intracranial aneurysm	2.19e-05	0.00152	CbGpPWpGaD
Irbesartan—EDNRA—brain—intracranial aneurysm	2.07e-05	0.0376	CbGeAlD
Irbesartan—JUN—Signaling Pathways—EDNRA—intracranial aneurysm	2.06e-05	0.00143	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	1.92e-05	0.00134	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	1.91e-05	0.00133	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	1.9e-05	0.00132	CbGpPWpGaD
Irbesartan—JUN—brain—intracranial aneurysm	1.89e-05	0.0343	CbGeAlD
Irbesartan—EDNRA—Signaling Pathways—CCL2—intracranial aneurysm	1.73e-05	0.00121	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	1.63e-05	0.00113	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—intracranial aneurysm	1.55e-05	0.00107	CbGpPWpGaD
Irbesartan—AGTR1—brain—intracranial aneurysm	1.43e-05	0.0259	CbGeAlD
Irbesartan—AGTR1—Signaling Pathways—CCL2—intracranial aneurysm	1.36e-05	0.000946	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—intracranial aneurysm	1.34e-05	0.000934	CbGpPWpGaD
Irbesartan—CYP2D6—brainstem—intracranial aneurysm	1.29e-05	0.0233	CbGeAlD
Irbesartan—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	1.26e-05	0.000874	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—intracranial aneurysm	1.24e-05	0.000862	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—intracranial aneurysm	1.21e-05	0.000843	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—intracranial aneurysm	1.02e-05	0.000707	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—intracranial aneurysm	9.73e-06	0.000677	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—intracranial aneurysm	9.06e-06	0.00063	CbGpPWpGaD
Irbesartan—CYP2C8—brain—intracranial aneurysm	7.73e-06	0.014	CbGeAlD
Irbesartan—PTGS1—Metabolism—NOS3—intracranial aneurysm	7.57e-06	0.000526	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—intracranial aneurysm	7.27e-06	0.000505	CbGpPWpGaD
Irbesartan—CYP2D6—cerebellum—intracranial aneurysm	6.34e-06	0.0115	CbGeAlD
Irbesartan—PTGS1—brain—intracranial aneurysm	6.27e-06	0.0114	CbGeAlD
Irbesartan—CYP2D6—brain—intracranial aneurysm	5.15e-06	0.00934	CbGeAlD
Irbesartan—CYP2C8—Metabolism—NOS3—intracranial aneurysm	4.89e-06	0.00034	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—intracranial aneurysm	4.01e-06	0.000279	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—intracranial aneurysm	3.98e-06	0.000276	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—intracranial aneurysm	3.4e-06	0.000236	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—intracranial aneurysm	2.62e-06	0.000182	CbGpPWpGaD
